Evaluation of three different sample populations on a new multiplex BioPlex®2200 assay for the detection of measles, Mumps, and Varicella-Zoster virus IgM antibodies

MLA

C. Tatyosian, et al. “Evaluation of Three Different Sample Populations on a New Multiplex BioPlex®2200 Assay for the Detection of Measles, Mumps, and Varicella-Zoster Virus IgM Antibodies.” Journal of Clinical Virology, vol. 82, Sept. 2016, pp. S50–51. EBSCOhost, https://doi.org/10.1016/j.jcv.2016.08.099.

APA

C. Tatyosian, J. Vogel, C. Todd, R. Del Rosario, J. Flanagan, & David L. King. (2016). Evaluation of three different sample populations on a new multiplex BioPlex®2200 assay for the detection of measles, Mumps, and Varicella-Zoster virus IgM antibodies. Journal of Clinical Virology, 82, S50–S51. https://doi.org/10.1016/j.jcv.2016.08.099

Chicago

C. Tatyosian, J. Vogel, C. Todd, R. Del Rosario, J. Flanagan, and David L. King. 2016. “Evaluation of Three Different Sample Populations on a New Multiplex BioPlex®2200 Assay for the Detection of Measles, Mumps, and Varicella-Zoster Virus IgM Antibodies.” Journal of Clinical Virology 82 (September): S50–51. doi:10.1016/j.jcv.2016.08.099.